← Back to Search

Hemodialysis for Chronic Kidney Failure

N/A
Waitlist Available
Led By Tammy Sirich, MD
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will see if patients with some kidney function will do better with two hemodialysis treatments a week, instead of the usual three.

Who is the study for?
This trial is for stable dialysis patients who can consent to participate. It's not for those who've used antibiotics in the last two months, expect to use them soon, were recently hospitalized, or have very low residual kidney function (<2.5 mL/min).
What is being tested?
The study compares the effectiveness of hemodialysis twice a week versus the standard three times a week in patients who still have some kidney function left.
What are the potential side effects?
Potential side effects may include cramping, low blood pressure during treatment, fatigue after sessions, and possible changes in remaining kidney function.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
QOL: KDQOL36
Secondary study objectives
Cognition
Solute Concentration
Symptom

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Twice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis twice per week.
Group II: Thrice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis three times per week.

Find a Location

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor
55 Previous Clinical Trials
8,302 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,448 Previous Clinical Trials
4,332,354 Total Patients Enrolled
Tammy Sirich, MDPrincipal Investigator - Stanford/VA Palo Alto Health Care System
Palo Alto Veterans Institute for Research

Media Library

Twice weekly hemodialysis Clinical Trial Eligibility Overview. Trial Name: NCT03874117 — N/A
Chronic Kidney Failure Research Study Groups: Twice weekly hemodialysis, Thrice weekly hemodialysis
Chronic Kidney Failure Clinical Trial 2023: Twice weekly hemodialysis Highlights & Side Effects. Trial Name: NCT03874117 — N/A
Twice weekly hemodialysis 2023 Treatment Timeline for Medical Study. Trial Name: NCT03874117 — N/A
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top